摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-aniline; sulfate | 84803-70-3

中文名称
——
中文别名
——
英文名称
N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-aniline; sulfate
英文别名
N-Benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-anilin; Sulfat;Sulfat vom F:166grad;Antazoline Sulfate;N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline;sulfuric acid
<i>N</i>-benzyl-<i>N</i>-(4,5-dihydro-1<i>H</i>-imidazol-2-ylmethyl)-aniline; sulfate化学式
CAS
84803-70-3
化学式
C17H19N3*H2O4S
mdl
——
分子量
363.437
InChiKey
UWOSJBSLQYMGDL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.04
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    111
  • 氢给体数:
    3
  • 氢受体数:
    6

SDS

SDS:cdfc682f6c60e6d973c39d9705c8c39a
查看

文献信息

  • Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
    申请人:AMERICAN CYANAMID COMPANY
    公开号:EP0386960A2
    公开(公告)日:1990-09-12
    There is provided a pharmaceutical composition which comprises an aqueous vehicle, a compound having reversible thermosetting gel properties and a compound having film-forming properties. Depending on the relative proportions of these components, the composition can be adapted to function either as a vehicle for delivering pharmacologically or diagnostically active compounds to a human or animal patient and/or as a wound dressing composition.
    本发明提供了一种药物组合物,它包括一种水性载体、一种具有可逆热固性凝胶特性的化合物和一种具有成膜特性的化合物。根据这些成分的相对比例,该组合物既可用作向人类或动物患者输送药理或诊断活性化合物的载体,也可用作伤口敷料组合物。
  • Materials useful in human and veterinary medicine
    申请人:AMERICAN CYANAMID COMPANY
    公开号:EP0481600A2
    公开(公告)日:1992-04-22
    There is provided a solid material useful in medicine, especially a film material for use as a wound dressing or as a drug delivery vehicle, which comprises a molecular mixture of (a) a compound which has film-forming properties, for example hydroxyethylcellulose, hydroxypropylmethylcellulose or polyvinyl alcohol, and (b) a polyoxyethylene-polyoxypropylene block copolymer or a tetrasubstituted derivative of ethylene-diamine in which the substituents are block copolymers of polyoxyethylene-polyoxypropylene, as a modifier. The molecular mixture may be formed, for example, by evaporating a solution of the two components (a) and (b) in a solvent, or by cooling a liquid composition comprising at least one of components (a) and (b) in molten form from an elevated temperature.
    本发明提供了一种用于医药的固体材料,特别是一种用作伤口敷料或给药载体的薄膜材料,它包括以下物质的分子混合物:(a) 一种具有成膜特性的化合物,例如羟乙基纤维素、羟丙基甲基纤维素或聚乙烯醇,以及(b) 聚氧乙烯-聚氧丙烯嵌段共聚物或乙烯-二甲基纤维素的四代衍生物、(b) 作为改性剂的聚氧乙烯-聚氧丙烯嵌段共聚物或乙二胺的四取代衍生物,其中的取代基为聚氧乙烯-聚氧丙烯嵌段共聚物。分子混合物可通过以下方式形成:例如,蒸发两种组分(a)和(b)在溶剂中的溶液,或从高温下冷却包含至少一种熔融状态组分(a)和(b)的液体组合物。
  • An otorhinological drug delivery device
    申请人:Schering Oy
    公开号:EP1438942A1
    公开(公告)日:2004-07-21
    The invention relates to an otorhinological delivery device comprising at least one pharmaceutically active agent. According to the invention the device comprises a core comprising said at least one pharmaceutically active agent wherein said core is made of an elastomer composition selected from the group consisting of poly(dimethylsiloxane), a siloxane-based elastomer comprising 3,3,3-trifluoropropyl groups attached to the Si-atoms of the siloxane units, a siloxane-based elastomer comprising poly(alkylene oxide) groups and mixtures thereof.
    本发明涉及一种包含至少一种药用活性剂的耳鼻喉给药装置。根据本发明,该装置包括一个包含所述至少一种药物活性剂的芯体,其中所述芯体由弹性体组合物制成,该弹性体组合物选自聚(二甲基硅氧烷)、硅氧烷基弹性体(包含连接到硅氧烷单元S原子上的3,3,3-三氟丙基)、硅氧烷基弹性体(包含聚(环氧烷)基团)及其混合物组成的组。
  • Systems, Methods, and Devices for Rehabilitation of Auditory System Disorders Using Pharmaceutical Agents and Auditory Devices
    申请人:Hanley Peter J.
    公开号:US20110245235A1
    公开(公告)日:2011-10-06
    The present inventions provide combination therapies, kits, and methods for providing relief and/or for improving one or more symptoms associated with an auditory system disorder in a subject diagnosed with the auditory system disorder, comprising an effective amount of at least one pharmaceutical agent and at least one auditory system disorder device, as well as methods for using at least one pharmaceutical agent and/or at least one auditory system disorder device in the manufacture of said kits.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐